For the year ending 2025-12-31, ADMA has $624,242K in assets. $146,922K in debts. $87,630K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 87,630 | |||
| Accounts receivable, net | 158,429 | |||
| Inventories, net | 206,465 | |||
| Prepaid expenses and other current assets | 7,458 | |||
| Assets held for sale | 6,530 | |||
| Total current assets | 466,512 | |||
| Property and equipment, gross | 103,405 | |||
| Less accumulated depreciation | 38,348 | |||
| Property and equipment, net | 65,057 | |||
| Intangible assets, net | 632 | |||
| Goodwill | 3,530 | |||
| Deferred tax assets, net | 73,261 | |||
| Right-of-use assets | 6,650 | |||
| Deposits and other assets | 8,600 | |||
| Total assets | 624,242 | |||
| Accounts payable | 22,519 | |||
| Accrued expenses and other current liabilities | 40,466 | |||
| Current portion of long-term debt | 2,813 | |||
| Current portion of lease obligations | 1,096 | |||
| Liabilities held for sale | 2,647 | |||
| Total current liabilities | 69,541 | |||
| Long-term debt | 69,330 | |||
| Deferred revenue, net of current portion | 1,405 | |||
| End of term fee | 0 | |||
| Lease obligations, net of current portion | 6,646 | |||
| Other non-current liabilities | 0 | |||
| Total liabilities | 146,922 | |||
| Common stock - voting, 0.0001 par value, 300,000,000 shares authorized, december 31, 2025 239,793,566 issued and 237,874,496 outstanding december 31, 2024 236,620,545 issued and outstanding | 24 | |||
| Treasury stock, at cost, 1,919,070 and 0 shares as of december 31, 2025 and december 31, 2024, respectively | 32,090 | |||
| Additional paid-in capital | 671,039 | |||
| Accumulated deficit | -161,653 | |||
| Total stockholders equity | 477,320 | |||
| Total liabilities and stockholders equity | 624,242 | |||
ADMA BIOLOGICS, INC. (ADMA)
ADMA BIOLOGICS, INC. (ADMA)